306 related articles for article (PubMed ID: 18432283)
1. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
[TBL] [Abstract][Full Text] [Related]
2. Influence of N-hexane inhalation on the enantioselective pharmacokinetics and metabolism of verapamil in rats.
Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
Chirality; 2010 Jan; 22(1):29-34. PubMed ID: 19229957
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous analysis of the enantiomers of verapamil and norverapamil in rat plasma by liquid chromatography-tandem mass spectrometry.
Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
J Pharm Biomed Anal; 2007 Dec; 45(5):762-8. PubMed ID: 17981422
[TBL] [Abstract][Full Text] [Related]
4. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
Kim HJ; Choi JS
Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification of the enantiomers of verapamil and its N-demethylated metabolite in human plasma using liquid chromatography-tandem mass spectrometry.
Hedeland M; Fredriksson E; Lennernäs H; Bondesson U
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):303-11. PubMed ID: 15081924
[TBL] [Abstract][Full Text] [Related]
6. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
Piao YJ; Choi JS
Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
[TBL] [Abstract][Full Text] [Related]
7. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective distribution of verapamil and norverapamil into human and rat erythrocytes: the role of plasma protein binding.
Robinson MA; Mehvar R
Biopharm Drug Dispos; 1996 Oct; 17(7):577-87. PubMed ID: 8894116
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of verapamil and norverapamil enantiomers after administration of immediate and controlled-release formulations to humans:evidence suggesting input-rate determined stereoselectivity.
Bhatti MM; Lewanczuk RZ; Pasutto FM; Foster RT
J Clin Pharmacol; 1995 Nov; 35(11):1076-82. PubMed ID: 8626881
[TBL] [Abstract][Full Text] [Related]
10. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human.
Dadashzadeh S; Javadian B; Sadeghian S
Biopharm Drug Dispos; 2006 Oct; 27(7):329-34. PubMed ID: 16892180
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats.
Hanada K; Ikemi Y; Kukita K; Mihara K; Ogata H
Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604
[TBL] [Abstract][Full Text] [Related]
12. Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers.
Boralli VB; Coelho EB; Sampaio SA; Marques MP; Lanchote VL
J Clin Pharmacol; 2009 Feb; 49(2):205-11. PubMed ID: 19033449
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
Chung JH; Choi DH; Choi JS
Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
[TBL] [Abstract][Full Text] [Related]
14. Impact of inhalational exposure to ethanol fuel on the pharmacokinetics of verapamil, ibuprofen and fluoxetine as in vivo probe drugs for CYP3A, CYP2C and CYP2D in rats.
Cardoso JL; Lanchote VL; Pereira MP; Capela JM; de Moraes NV; Lepera JS
Food Chem Toxicol; 2015 Oct; 84():99-105. PubMed ID: 26265240
[TBL] [Abstract][Full Text] [Related]
15. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD
Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective pharmacokinetics of lercanidipine in healthy volunteers.
Jabor VA; Coelho EB; Lanchote VL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):343-6. PubMed ID: 15556551
[TBL] [Abstract][Full Text] [Related]
17. Effects of grapefruit juice and smoking on verapamil concentrations in steady state.
Fuhr U; Müller-Peltzer H; Kern R; Lopez-Rojas P; Jünemann M; Harder S; Staib AH
Eur J Clin Pharmacol; 2002 Apr; 58(1):45-53. PubMed ID: 11956673
[TBL] [Abstract][Full Text] [Related]
18. A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human.
Wang J; Xia S; Xue W; Wang D; Sai Y; Liu L; Liu X
Eur J Pharm Sci; 2013 Nov; 50(3-4):290-302. PubMed ID: 23916407
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the enantiomers of verapamil in the dog.
Bai SA; Lankford SM; Johnson LM
Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
[TBL] [Abstract][Full Text] [Related]
20. Achiral and chiral HPLC analysis of norverapamil and its metabolites in microsomal samples.
Brandsteterová E; Wainer IW; Tracy T
Neoplasma; 1999; 46(4):207-11. PubMed ID: 10613599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
